How does increased antibiotic use impact Enterobacteriaceae?

How does increased antibiotic use impact Enterobacteriaceae?

• A. It reduces the necessity for culture
• B. It promotes the development of resistant strains
• C. It eliminates infections faster
• D. It decreases pathogen virulence

Answer: (B)

Increased antibiotic use significantly impacts Enterobacteriaceae by promoting the development of resistant strains. When antibiotics are used, especially without appropriate medical oversight or in inappropriate contexts, susceptible bacteria are killed or inhibited, while those with mutations or mechanisms that confer resistance survive and proliferate. This survival advantage means that over time, the population of bacteria becomes increasingly composed of resistant strains, making infections harder to treat effectively. This situation poses a major public health challenge, as infections caused by resistant Enterobacteriaceae, such as Escherichia coli and Klebsiella pneumoniae, can lead to longer hospital stays, higher medical costs, and increased mortality. As resistant strains become more prevalent, it becomes increasingly difficult for healthcare providers to manage infections effectively, further contributing to the cycle of antibiotic resistance. Other choices do not accurately depict the impact of antibiotic use on Enterobacteriaceae. For example, while culture may become less necessary in some contexts due to prior antibiotic treatment, this does not address the critical issue of resistance development. Similarly, while antibiotics can lead to faster elimination of infections in some cases, this benefit is overshadowed by the risks of promoting resistance. The idea that antibiotic use decreases pathogen virulence is also misleading, as the emergence of resistant strains can

Increased antibiotic use significantly impacts Enterobacteriaceae by promoting the development of resistant strains. When antibiotics are used, especially without appropriate medical oversight or in inappropriate contexts, susceptible bacteria are killed or inhibited, while those with mutations or mechanisms that confer resistance survive and proliferate. This survival advantage means that over time, the population of bacteria becomes increasingly composed of resistant strains, making infections harder to treat effectively.

This situation poses a major public health challenge, as infections caused by resistant Enterobacteriaceae, such as Escherichia coli and Klebsiella pneumoniae, can lead to longer hospital stays, higher medical costs, and increased mortality. As resistant strains become more prevalent, it becomes increasingly difficult for healthcare providers to manage infections effectively, further contributing to the cycle of antibiotic resistance.

Other choices do not accurately depict the impact of antibiotic use on Enterobacteriaceae. For example, while culture may become less necessary in some contexts due to prior antibiotic treatment, this does not address the critical issue of resistance development. Similarly, while antibiotics can lead to faster elimination of infections in some cases, this benefit is overshadowed by the risks of promoting resistance. The idea that antibiotic use decreases pathogen virulence is also misleading, as the emergence of resistant strains can